Advice
Following a full submission.
Tigecycline (Tygacil) is accepted for restricted use within NHS Scotland for the treatment of complicated intra-abdominal infection.
Tigecycline is associated with clinical cure rates in patients with complicated intra-abdominal infections non-inferior to those with a broad-spectrum beta-lactam antibiotic. It is restricted to 2nd line use under the advice of local microbiologists or specialists in infectious disease.
Download detailed advice43KB (PDF)
Medicine details
- Medicine name:
- Tigecycline 50mg vial of powder tigecycline for intravenous infusion (Tygacil®)
- SMC ID:
- 277/06
- Indication:
- Complicated intra-abdominal infection
- Pharmaceutical company
- Wyeth Pharmaceuticals
- BNF chapter
- Infections
- Submission type
- Full
- Status
- Restricted
- Date advice published
- 10 July 2006